Cleveland, OHNCT06263153Now EnrollingIRB Ready

Bladder Cancer Clinical Trial in Cleveland, OH

Access cutting-edge bladder cancer treatment through this clinical trial at a research site in Cleveland. Study-provided care at no cost to qualified participants.

Sponsored by Yuanquan Yang

Quick Self-Assessment

See if you qualify for this Cleveland location

Preparing your pre-screening questions...

Expert Care in Cleveland

Access bladder cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related bladder cancer treatment provided free

Apply for This Cleveland Location

Check if you qualify for this bladder cancer clinical trial in Cleveland, OH

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Cleveland

    Convenient for OH residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Cleveland site if eligible
  4. 4Begin participation

About This Bladder Cancer Study in Cleveland

This phase II trial tests how well the combination of futibatinib and durvalumab given before cystectomy works in treating patients with muscle-invasive bladder cancer (MIBC) who are ineligible for cisplatin-based therapy. Cisplatin-based therapy is the standard of care for patients with MIBC. However, many patients cannot receive standard therapy due to poor renal function, peripheral neuropathy, poor functional status, or clinically significant heart failure. Futibatinib may stop the growth of

Sponsor: Yuanquan Yang

Who Can Participate

Inclusion Criteria

Able to provide signed informed consent
Female or male subjects \>= 18 years old
Bodyweight \>30kg
FGFR1, 2, or 3 overexpression as defined by a score of 3+ or 4+ on ribonucleic acid (RNA) in-situ hybridization (RNAScope assay)
Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2
Histologically confirmed urothelial carcinoma of the bladder
Mixed histologies are permitted if urothelial carcinoma is the predominant histology ( \>= 50%)
Clinical stage T2-T4a, N0, M0 disease by trans urethral removal of bladder tumour (TURBT) and imaging studies (stage II-IIIA per American Joint Committee on Cancer \[AJCC\] 2018)
Refuse or ineligible for cisplatin-based neoadjuvant chemotherapy as defined by any of the following:
ECOG performance status (PS) \> 1
Creatinine clearance (calculated or measured) \< 60 mL/min as measured by the Cockcroft-Gault formula
Common Terminology Criteria for Adverse Events version 5.0 (CTCAE v

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Cleveland?

Yes, this clinical trial (NCT06263153) has an active research site in Cleveland, OH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Bladder Cancer Treatment Options in Cleveland, OH

If you're searching for bladder cancer treatment options in Cleveland, OH, this clinical trial (NCT06263153) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Cleveland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced bladder cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all bladder cancer clinical trials near you to find additional studies recruiting in your area.

More Bladder Cancer Trials in Cleveland, OH

See all bladder cancer clinical trials recruiting in Cleveland — not just this study.

Browse Bladder Cancer Trials in Cleveland

Ready to Join in Cleveland?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Cleveland, OH